MARKER THERAPEUTICS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
MARKER THERAPEUTICS, INC. (MRKR) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$6.10 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2025-03-31
- MARKER THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-12-31 was -$62.94K.
- MARKER THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-09-30 was -$260.28K.
- MARKER THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-06-30 was -$2.99M.
- MARKER THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-03-31 was -$2.79M.
- MARKER THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2023 was -$6.10M.
- MARKER THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2022 was -$5.46M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$62.94K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$323.22K derived: sum of 2 quarters · filed 2025-03-31 | -$3.31M derived: sum of 3 quarters · filed 2025-03-31 | -$6.10M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$260.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$3.25M derived: sum of 2 quarters · filed 2024-11-14 | -$6.04M 10-Q · filed 2024-11-14 | -$8.24M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$5.78M 10-Q · filed 2024-08-14 | -$7.98M derived: sum of 3 quarters · filed 2024-08-14 | -$10.38M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$2.79M 10-Q · filed 2024-05-15 | -$4.99M derived: sum of 2 quarters · filed 2024-05-15 | -$7.39M derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$4.60M derived: sum of 2 quarters · filed 2024-03-26 | -$5.46M 10-K · filed 2024-03-26 | |
| 2022-09-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$3.26M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$856.92K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |